Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: NON-SMALL-CELL LUNG, . Treffer: 38

2022

Heitzer, E; van den Broek, D; Denis, MG; Hofman, P; Hubank, M; Mouliere, F; Paz-Ares, L; Schuuring, E; Sultmann, H; Vainer, G; Verstraaten, E; de Visser, L; Cortinovis, D Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
ESMO OPEN. 2022; 7(2): 100399 Doi: 10.1016/j.esmoop.2022.100399 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hochmair, MJ; Kolb, R; Wurm, R; Zach, H; Bittner, N Nintedanib plus Docetaxel after Immune Checkpoint Inhibitor Failure in Patients with Advanced Non-Small-Cell Lung Cancer: A Case Series
CASE REP ONCOL. 2022; 15(1): 138-148. Doi: 10.1159/000520939 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Buergy, D; Würschmidt, F; Gkika, E; Hörner-Rieber, J; Knippen, S; Gerum, S; Balermpas, P; Henkenberens, C; Voglhuber, T; Kornhuber, C; Barczyk, S; Röper, B; Rashid, A; Blanck, O; Wittig, A; Herold, HU; Brunner, TB; Klement, RJ; Kahl, KH; Ciernik, IF; Ottinger, A; Izaguirre, V; Putz, F; König, L; Hoffmann, M; Combs, SE; Guckenberger, M; Boda-Heggemann, J Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis.
Int J Cancer. 2021; 149(2): 358-370. Doi: 10.1002/ijc.33546
Web of Science PubMed FullText FullText_MUG

 

Stitz, R; Buder, A; Silye, R; Baumgartner, B; Pühringer, F; Filipits, M; Oberndorfer, E; Heitzer, E Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNA.
EXP MOL PATHOL. 2021; 123: 104685 Doi: 10.1016/j.yexmp.2021.104685
Web of Science PubMed FullText FullText_MUG

 

Weber, S; van der Leest, P; Donker, HC; Schlange, T; Timens, W; Tamminga, M; Hasenleithner, SO; Graf, R; Moser, T; Spiegl, B; Yaspo, ML; Terstappen, LWMM; Sidorenkov, G; Hiltermann, TJN; Speicher, MR; Schuuring, E; Heitzer, E; Groen, HJM Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
JCO PRECIS ONCOL. 2021; 5: 1540-1553. Doi: 10.1200/PO.21.00182
Web of Science PubMed FullText FullText_MUG

 

2020

Chamberlain, S; Bellnier, D; Yendamuri, S; Lindenmann, J; Demmy, T; Nwogu, C; Ramer, M; Tworek, L; Oakley, E; Mallory, M; Carlsen, L; Sexton, S; Curtin, L; Shafirstein, G An Optical Surface Applicator for Intraoperative Photodynamic Therapy.
Lasers Surg Med. 2020; 52(6):523-529 Doi: 10.1002/lsm.23168 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fink-Neuboeck, N; Lindenmann, J; Porubsky, C; Fediuk, M; Anegg, U; Maier, A; Smolle, J; Lamont, E; Smolle-Juettner, FM Hazards of Recurrence, Second Primary, or Other Tumor at Ten Years After Surgery for Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2020; 21(4):333-340 Doi: 10.1016/j.cllc.2020.02.011
Web of Science PubMed FullText FullText_MUG

 

Hochmair, MJ; Fabikan, H; Illini, O; Weinlinger, C; Setinek, U; Krenbek, D; Prosch, H; Rauter, M; Schumacher, M; Wöll, E; Wass, R; Brehm, E; Absenger, G; Bundalo, T; Errhalt, P; Urban, M; Valipour, A Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis.
PHARMACEUTICALS-BASE. 2020; 13(11): Doi: 10.3390/ph13110371 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Maier, A; Kovacs, G; Balic, M; Smolle, J; Smolle-Juettner, FM Preoperative Peak Oxygen Consumption: A Predictor of Survival in Resected Lung Cancer.
Cancers (Basel). 2020; 12(4): Doi: 10.3390/cancers12040836 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Safi, S; Yamauchi, Y; Hoffmann, H; Weichert, W; Jost, PJ; Winter, H; Muley, T; Beckhove, P Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer.
Cancers (Basel). 2020; 12(12): Doi: 10.3390/cancers12123496 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Riedmann, K; Bassermann, F; Jost, PJ [Kinase inhibitors in oncology : What is new?]
Internist (Berl). 2019; 60(5):540-544 Doi: 10.1007/s00108-019-0577-8
Web of Science PubMed FullText FullText_MUG

 

2018

Brcic, L; Stanzer, S; Krenbek, D; Gruber-Moesenbacher, U; Absenger, G; Quehenberger, F; Valipour, A; Lindenmann, J; Stoeger, H; Al Effah, M; Fediuk, M; Balic, M; Popper, HH Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.
Virchows Arch. 2018; 472(4):589-598 Doi: 10.1007/s00428-018-2326-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Buder, A; Hochmair, MJ; Schwab, S; Bundalo, T; Schenk, P; Errhalt, P; Mikes, RE; Absenger, G; Patocka, K; Baumgartner, B; Setinek, U; Burghuber, OC; Prosch, H; Pirker, R; Filipits, M Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.
J Thorac Oncol. 2018; 13(6):821-830 Doi: 10.1016/j.jtho.2018.02.014 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gandhi, L; Rodríguez-Abreu, D; Gadgeel, S; Esteban, E; Felip, E; De Angelis, F; Domine, M; Clingan, P; Hochmair, MJ; Powell, SF; Cheng, SY; Bischoff, HG; Peled, N; Grossi, F; Jennens, RR; Reck, M; Hui, R; Garon, EB; Boyer, M; Rubio-Viqueira, B; Novello, S; Kurata, T; Gray, JE; Vida, J; Wei, Z; Yang, J; Raftopoulos, H; Pietanza, MC; Garassino, MC; KEYNOTE-189 Investigators Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med. 2018; 378(22): 2078-2092. Doi: 10.1056/NEJMoa1801005
Web of Science PubMed FullText FullText_MUG

 

2017

Absenger, G; Terzic, J; Bezan, A ASCO update: lung cancer.
Memo. 2017; 10(4):224-227 Doi: 10.1007/s12254-017-0373-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kargl, J; Busch, SE; Yang, GH; Kim, KH; Hanke, ML; Metz, HE; Hubbard, JJ; Lee, SM; Madtes, DK; McIntosh, MW; Houghton, AM Neutrophils dominate the immune cell composition in non-small cell lung cancer.
Nat Commun. 2017; 8(5):14381-14381 Doi: 10.1038/ncomms14381 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Brambilla, E; Le Teuff, G; Marguet, S; Lantuejoul, S; Dunant, A; Graziano, S; Pirker, R; Douillard, JY; Le Chevalier, T; Filipits, M; Rosell, R; Kratzke, R; Popper, H; Soria, JC; Shepherd, FA; Seymour, L; Tsao, MS Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.
J CLIN ONCOL. 2016; 34(11): 1223-1230. Doi: 10.1200/JCO.2015.63.0970 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Jacobsen, PB; Lee, JH; Fulp, W; Siegel, EM; Shibata, D; Laronga, C; Gray, J; Tanvetyanon, T; Schreiber, F; Brown, R; Levine, R; Cartwright, T; Abesada-Terk, G; Kim, G; Alemany, C; Faig, D; Sharp, P; Markham, MJ; Malafa, M Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year Interval.
J Oncol Pract. 2015; 11(1):e103-e109 Doi: 10.1200/JOP.2014.001525 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ramlau, R; Cufer, T; Berzinec, P; Dziadziuszko, R; Olszewski, W; Popper, H; Bajcic, P; Dusšk, L; Zbozinkova, Z; Pirker, R; INSIGHT study team Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe: The INSIGHT Study.
J Thorac Oncol. 2015; 10(9):1370-1374 Doi: 10.1097/JTO.0000000000000621 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Ediebah, DE; Coens, C; Zikos, E; Quinten, C; Ringash, J; King, MT; Schmucker von Koch, J; Gotay, C; Greimel, E; Flechtner, H; Weis, J; Reeve, BB; Smit, EF; Taphoorn, MJ; Bottomley, A Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
Br J Cancer. 2014; 110(10):2427-2433 Doi: 10.1038/bjc.2014.208 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ma, X; Rousseau, V; Sun, H; Lantuejoul, S; Filipits, M; Pirker, R; Popper, H; Mendiboure, J; Vataire, AL; Le Chevalier, T; Soria, JC; Brambilla, E; Dunant, A; Hainaut, P; IALT-Bio working group Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.
Mol Oncol. 2014; 8(3):555-564 Doi: 10.1016/j.molonc.2013.12.015 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zinrajh, D; Hörl, G; Jürgens, G; Marc, J; Sok, M; Cerne, D Increased phosphatidylethanolamine N-methyltransferase gene expression in non-small-cell lung cancer tissue predicts shorter patient survival.
Oncol Lett. 2014; 7(6):2175-2179 Doi: 10.3892/ol.2014.2035 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Shirsath, N; Rathos, M; Chaudhari, U; Sivaramakrishnan, H; Joshi, K Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Lung Cancer. 2013; 82(2):214-221 Doi: 10.1016/j.lungcan.2013.08.010
Web of Science PubMed FullText FullText_MUG

 

2012

Schoellnast, H; Deodhar, A; Hsu, M; Moskowitz, C; Nehmeh, SA; Thornton, RH; Sofocleous, CT; Alago, W; Downey, RJ; Azzoli, CG; Rosenzweig, KE; Solomon, SB Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy.
Acta Radiol. 2012; 53(8):893-899 Doi: 10.1258/ar.2012.110333
Web of Science PubMed FullText FullText_MUG

 

2011

Maringwa, JT; Quinten, C; King, M; Ringash, J; Osoba, D; Coens, C; Martinelli, F; Vercauteren, J; Cleeland, CS; Flechtner, H; Gotay, C; Greimel, E; Taphoorn, MJ; Reeve, BB; Koch, JS; Weis, J; Smit, EF; van Meerbeeck, JP; Bottomley, A; EORTC PROBE project and the Lung Cancer Group Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
SUPPORT CARE CANCER. 2011; 19(11): 1753-1760. Doi: 10.1007/s00520-010-1016-5
Web of Science PubMed FullText FullText_MUG

 

Schoellnast, H; Larson, SM; Nehmeh, SA; Carrasquillo, JA; Thornton, RH; Solomon, SB Radiofrequency Ablation of Lung Tumours with the Patient Under Thoracic Epidural Anaesthesia
CARDIOVASC INTERVEN RADIOL. 2011; 34: S182-S185. Doi: 10.1007/s00270-010-9898-7
Web of Science PubMed FullText FullText_MUG

 

2010

Watzka, SB; Rauscher-Pötsch, I; Stubenberger, E; Getman, V; Setinek, U; Tötsch, M; Pötschger, U; Müller, MR Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection.
Eur J Cardiothorac Surg. 2010; 38(3):254-259 Doi: 10.1016/j.ejcts.2010.02.006 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Pollheimer, MJ; Eberl, T; Baumgartner, K; Pollheimer, VS; Tschmelitsch, J; Lackner, H; Langner, C Ileocecal intussusception caused by lung cancer metastasis.
WIEN KLIN WOCHENSCHR. 2009; 121(11-12): 413-416. Doi: 10.1007/s00508-009-1146-2 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2007

Filipits, M; Pirker, R; Dunant, A; Lantuejoul, S; Schmid, K; Huynh, A; Haddad, V; André, F; Stahel, R; Pignon, JP; Soria, JC; Popper, HH; Le Chevalier, T; Brambilla, E Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
J Clin Oncol. 2007; 25(19): 2735-2740. Doi: 10.1200/JCO.2006.08.2867 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Betticher, DC; Hsu Schmitz, SF; Tötsch, M; Hansen, E; Joss, C; von Briel, C; Schmid, RA; Pless, M; Habicht, J; Roth, AD; Spiliopoulos, A; Stahel, R; Weder, W; Stupp, R; Egli, F; Furrer, M; Honegger, H; Wernli, M; Cerny, T; Ris, HB; Swiss Group for Clinical Cancer Research (SAKK) Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study.
Br J Cancer. 2006; 94(8):1099-1106 Doi: 10.1038/sj.bjc.6603075 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Olaussen, KA; Dunant, A; Fouret, P; Brambilla, E; André, F; Haddad, V; Taranchon, E; Filipits, M; Pirker, R; Popper, HH; Stahel, R; Sabatier, L; Pignon, JP; Tursz, T; Le Chevalier, T; Soria, JC; IALT Bio Investigators DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
N ENGL J MED. 2006; 355: 983-991. Doi: 10.1056/NEJMoa060570 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2004

Gabor, S; Renner, H; Popper, H; Anegg, U; Sankin, O; Matzi, V; Lindenmann, J; Smolle Jüttner, FM Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer.
EUR J CARDIO-THORAC SURG. 2004; 25(3): 439-442. Doi: 10.1016/j.ejcts.2003.11.033 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

Betticher, DC; Hsu Schmitz, SF; Tötsch, M; Hansen, E; Joss, C; von Briel, C; Schmid, RA; Pless, M; Habicht, J; Roth, AD; Spiliopoulos, A; Stahel, R; Weder, W; Stupp, R; Egli, F; Furrer, M; Honegger, H; Wernli, M; Cerny, T; Ris, HB Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.
J Clin Oncol. 2003; 21(9):1752-1759 Doi: 10.1200/JCO.2003.11.040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2002

Ullmann, R; Petzmann, S; Klemen, H; Fraire, AE; Hasleton, P; Popper, HH The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues.
Genes Chromosomes Cancer. 2002; 34(1):78-85 Doi: 10.1002%2Fgcc.10049
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Prior, C; Oroszy, S; Oberaigner, W; Ambrosch, G; Mohn-Staudner, A; Pfeifer, W; Pirker, R; Huber, H Advanced non-small-cell lung cancer: adjunctive interferon gamma in induction and maintenance therapy.
J Cancer Res Clin Oncol. 1999; 125(1):42-46 Doi: 10.1007%2Fs004320050240
Web of Science PubMed FullText FullText_MUG

 

1990

Arian-Schad, KS; Juettner, FM; Ratzenhofer, B; Leitner, H; Porsch, G; Pinter, H; Ebner, F; Hackl, AG; Friehs, GB Intraoperative plus external beam irradiation in nonresectable lung cancer: assessment of local response and therapy-related side effects.
Radiother Oncol. 1990; 19(2):137-144 Doi: 10.1016/0167-8140(90)90127-i
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Juettner, FM; Arian-Schad, K; Leitner, G; Porsch, G; Flueckiger, G; Kopp, G; Ebner, F; Smolle, J; Popper, H; Hackl, A Intraoperative radiation with external irradiation: an alternative for nonresectable non-small-cell lung cancer?
Eur J Cardiothorac Surg. 1990; 4(2):85-89 Doi: 10.1016/1010-7940(90)90220-t
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Juettner, FM; Arian-Schad, K; Porsch, G; Leitner, H; Smolle, J; Ebner, F; Hackl, A; Friehs, G Intraoperative radiation therapy combined with external irradiation in nonresectable non-small-cell lung cancer: preliminary report.
Int J Radiat Oncol Biol Phys. 1990; 18(5):1143-1150 Doi: 10.1016/0360-3016(90)90451-o
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum